Cancer. Proteases--invasion and more.
Edwards
D R
DR
Murphy
G
G
D043168:Angiostatins; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002403:Cathepsins / Q000378:metabolism; D010450:Endopeptidases / Q000502:physiology*; D006801:Humans; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors / Q000378:metabolism; D009369:Neoplasms / Q000098:blood supply / Q000188:drug therapy / Q000201:enzymology*; D009389:Neovascularization, Pathologic / Q000188:drug therapy; D010446:Peptide Fragments / Q000627:therapeutic use; D010958:Plasminogen / Q000378:metabolism / Q000627:therapeutic use; D011480:Protease Inhibitors / Q000627:therapeutic use; D011956:Receptors, Cell Surface / Q000378:metabolism; D055293:Receptors, Urokinase Plasminogen Activator; D017154:Stromal Cells / Q000201:enzymology; D014568:Urokinase-Type Plasminogen Activator / Q000378:metabolism
D000970:Antineoplastic Agents; C524898:PLAUR protein, human; D010446:Peptide Fragments; D011480:Protease Inhibitors; D011956:Receptors, Cell Surface; D055293:Receptors, Urokinase Plasminogen Activator; D043168:Angiostatins; D010958:Plasminogen; D002403:Cathepsins; D010450:Endopeptidases; D014568:Urokinase-Type Plasminogen Activator; D008666:Metalloendopeptidases